What is NDC 60977-141?

60977-141 is the product NDC for Protopam Chloride (pralidoxime chloride), Pralidoxime chloride 1 g/20mL injection, powder, lyophilized, for solution, listed with the FDA by Baxter Healthcare Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Protopam Chloride (Pralidoxime chloride).

Baxter Healthcare Corporation, NDC labeler code 60977. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Protopam Chloride?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Protopam Chloride NDC 60977-141 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60977-141Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60977-0141Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60977-141-01	60977014101	6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01) / 20 mL in 1 VIAL, SINGLE-DOSE (60977-141-27)Marketed from Mar 10, 1965

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Protopam Chloride
Generic name (nonproprietary): pralidoxime chloride
Active ingredients: Pralidoxime chloride — 1 g/20mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intramuscular, Intravenous, Subcutaneous
Labeler: Baxter Healthcare CorporationNDC labeler code 60977
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 014134
Marketing start: Mar 10, 1965
Listing expires: Dec 31, 2027
Other FDA classes: Cholinesterase Reactivators (Mechanism)
Identifiers: Product ID 60977-141_ce0e8c50-0a21-4dbe-bdc6-e64a26a120c7SPL ID ce0e8c50-0a21-4dbe-bdc6-e64a26a120c7SPL set ID 2741d8fd-51c2-46be-880b-99f2b20a6137RxCUI 208969, 312576UNII 38X7XS076H
Pharmacologic class: Cholinesterase Reactivator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460977014101 followed by a unit qualifier and the quantity

Package 60977-0141-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE PROTOPAM Chloride is indicated as an antidote: (1) in the treatment of poisoning due to those pesticides and chemicals (e.g., nerve agents) of the organophosphate class which have anticholinesterase activity and (2) in the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis. The principal indications for the use of PROTOPAM Chloride are muscle weakness and respiratory depression. In severe poisoning, respiratory depression may be due to muscle weakness.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60977-141

What is NDC 60977-141?: 60977-141 is the product NDC for Protopam Chloride (pralidoxime chloride), Pralidoxime chloride 1 g/20mL injection, powder, lyophilized, for solution, listed with the FDA by Baxter Healthcare Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Protopam Chloride (Pralidoxime chloride).
What is the active ingredient?: Pralidoxime chloride.
Who is the labeler?: Baxter Healthcare Corporation, NDC labeler code 60977. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Protopam Chloride?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Protopam Chloride (Pralidoxime chloride) NDC 60977-141